B7-33 Vials represent a cutting-edge research product designed exclusively for scientific investigation and experimentation. This innovative formulation, synthesized through rigorous laboratory processes, is strictly intended for research purposes and is not intended for human consumption.
B7-33 Vials exhibit unique chemical properties, carefully curated for precision in laboratory studies. The formulation is characterized by its purity, stability, and reproducibility, ensuring reliable results in diverse research settings.
The versatility of B7-33 Vials makes them applicable across various fields of scientific exploration. Researchers can utilize these vials to delve into complex biological processes, making it an invaluable tool in advancing our understanding of specific cellular and molecular mechanisms.
B7-33 and Preeclampsia Phenotype
B7-33 demonstrates potential significance in the context of preeclampsia. Research studies have explored the relationship between B7-33 and the modulation of factors contributing to the preeclampsia phenotype. These studies suggest a promising avenue for further investigation into the underlying mechanisms and potential therapeutic implications.
B7-33 and Anti-Fibrotic Properties
Research on B7-33 has revealed its anti-fibrotic properties, as documented in these investigations pointing toward the potential of B7-33 in mitigating fibrotic processes within biological systems. This property opens avenues for research in conditions where fibrosis plays a pivotal role.
B7-33 and Blood Vessel
Studies shed light on the impact of B7-33 on blood vessel physiology. The research indicates that B7-33 may influence key factors related to blood vessel function. Further exploration in this area could provide valuable insights into cardiovascular health and related disorders.
B7-33 Vials offer researchers a unique tool for delving into intricate biological processes, with documented benefits in the realms of preeclampsia, anti-fibrosis, and blood vessel physiology. These vials stand as a testament to the continual progress in scientific exploration, providing a foundation for further investigations across diverse research domains.
- Hossain MA, Kocan M, Yao ST, Royce SG, Nair VB, Siwek C, Patil NA, Harrison IP, Rosengren KJ, Selemidis S, Summers RJ, Wade JD, Bathgate RAD, Samuel CS. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem Sci. 2016 Jun 1;7(6):3805-3819. doi: 10.1039/c5sc04754d. Epub 2016 Feb 26. PMID: 30155023; PMCID: PMC6013806. [Read More]
- Marshall SA, O’Sullivan K, Ng HH, Bathgate RAD, Parry LJ, Hossain MA, Leo CH. B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin). Eur J Pharmacol. 2017 Jul 15;807:190-197. doi: 10.1016/j.ejphar.2017.05.005. Epub 2017 May 3. PMID: 28478069. [Read More]